Yan Meng

Manager

Education

Ph.D., econometrics and business statistics, Monash University, Australia; M.S., international economics and finance, University of Queensland, Australia; B.Com., finance, University of Queensland, Australia

Summary of Experience

Dr. Meng is experienced in developing and applying novel statistical methods in health economics and outcomes research (HEOR). Her work spans multiple study types, including surveys, chart reviews, and real-world databases. She specializes in designing and implementing preference studies using survey-based instruments (e.g., discrete choice experiments) to elicit health preferences from diverse stakeholders and support decision-making throughout the product development lifecycle. Dr. Meng has conducted research across a broad range of diseases and therapeutic areas, including oncology, hematology, chronic diseases, rare diseases, neurodevelopmental disorders, and genetic disorders. Her research has been presented at major scientific conferences, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the American Society of Hematology (ASH), and the American Society of Clinical Oncology (ASCO), and has been published in leading clinical and health economics journals.